Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ligand Pharmaceuticals Incorporated - Common Stock (NQ:LGND)

227.44 -2.01 (-0.88%)

Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	235,407
Open	229.87
Bid (Size)	164.61 (100)
Ask (Size)	252.00 (100)
Prev. Close	229.45
Today's Range	226.47 - 236.22
52wk Range	98.89 - 247.38
Shares Outstanding	16,676,532
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Villere St Denis Dumps 134,000 Tidewater (TDW) Shares Worth $9.3 Million ↗

Today 11:08 EDT

Specializing in offshore marine support, Tidewater serves global energy clients across oil, gas, and windfarm projects.

Via The Motley Fool

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)

April 27, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Performance

YTD	+19.6%	+19.6%
1 Month	+14.0%	+14.0%
3 Month	+14.9%	+14.9%
6 Month	+18.9%	+18.9%
1 Year	+107.9%	+107.9%

More News

Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator

April 27, 2026

From XOMA Royalty Corporation

Via GlobeNewswire

Ligand Pharmaceuticals (NASDAQ:LGND) Passes Minervini Trend Template and Growth Screen ↗

April 01, 2026

Via Chartmill

Ligand Pharmaceuticals (NASDAQ:LGND) Beats Q4 Estimates and Reaffirms 2026 Guidance ↗

February 26, 2026

Via Chartmill

CLO Sells LGND 5,000 Shares for $1.0 Million ↗

March 30, 2026

Via The Motley Fool

Ligand Pharma CFO Sells $688K in Stock as Shares Surge 80% This Past Year. Here's What to Know ↗

March 27, 2026

Via The Motley Fool

Rice Hall James Buys QuidelOrtho Stock ↗

March 09, 2026

Via The Motley Fool

Rice Hall James Buys Stride Stock ↗

March 09, 2026

Via The Motley Fool

Ligand Pharma (LGND) Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

The Great Rotation: Small-Caps Break the Mega-Cap Monopoly in Early 2026

February 23, 2026

Via MarketMinute

This $38.8 Million Vicor Bet Is Getting Bigger Amid a 200% Stock Surge ↗

February 17, 2026

Via The Motley Fool

Sportradar Stock Down 26%, but One Fund Just Disclosed a New $12.6 Million Stake ↗

February 17, 2026

Via The Motley Fool

What Investors Should Know as One Fund Sells $11 Million of Cavco Industries Stock ↗

February 17, 2026

Via The Motley Fool

Fund Sells $23 Million in Globalstar as Stock Surges 170% in One Year ↗

February 17, 2026

Via The Motley Fool

Chime Is Down 27% From Its IPO Price, Yet Posting 29% Revenue Growth: Why This New $15 Million Bet Stands Out ↗

February 14, 2026

Via The Motley Fool

Solaris Stock Is Up 100% This Past Year, and One Fund Is Betting $29 Million on More Growth ↗

February 14, 2026

Via The Motley Fool

Stock Up 40% in a Year, $706 Million in Quarterly Sales: Why Boot Barn’s Trimmed Stake Deserves a Look ↗

February 14, 2026

Via The Motley Fool

Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year ↗

November 18, 2025

Via Investor's Business Daily

This Fund Sold $9 Million of Ligand Stock After an 84% Rally — What Investors Should Know ↗

November 17, 2025

Via The Motley Fool

Why One Small-Cap Fund Bought $11 Million in Cellebrite Stock Last Quarter ↗

November 17, 2025

Via The Motley Fool

This Fund Cut $7.3 Million of Atlas Energy Stock as the Company Suspends Its Dividend to Help Fuel Growth ↗

November 17, 2025

Via The Motley Fool

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

November 10, 2025

From Orchestra BioMed Holdings, Inc.

Via GlobeNewswire

EXCLUSIVE: Pelthos Secures Rights To Antimicrobial Drug, Raises $18 Million To Support Commercial Launch ↗

November 07, 2025

Via Benzinga

Ligand (LGND) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Via The Motley Fool

Frequently Asked Questions

Is Ligand Pharmaceuticals Incorporated - Common Stock publicly traded?

Yes, Ligand Pharmaceuticals Incorporated - Common Stock is publicly traded.

What exchange does Ligand Pharmaceuticals Incorporated - Common Stock trade on?

Ligand Pharmaceuticals Incorporated - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock?

The ticker symbol for Ligand Pharmaceuticals Incorporated - Common Stock is LGND on the Nasdaq Stock Market

What is the current price of Ligand Pharmaceuticals Incorporated - Common Stock?

The current price of Ligand Pharmaceuticals Incorporated - Common Stock is 227.44

When was Ligand Pharmaceuticals Incorporated - Common Stock last traded?

The last trade of Ligand Pharmaceuticals Incorporated - Common Stock was at 05/01/26 04:00 PM ET

What is the market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock?

The market capitalization of Ligand Pharmaceuticals Incorporated - Common Stock is 3.79B

How many shares of Ligand Pharmaceuticals Incorporated - Common Stock are outstanding?

Ligand Pharmaceuticals Incorporated - Common Stock has 4B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.